Table 1 Univariate analysis of clinical manifestations in control and case groups
From: Children systemic lupus erythematosus-associated pancreatitis
Variables | SLE with pancreatitis (N = 12) | SLE without pancreatitis (N = 48) | P |
|---|---|---|---|
Gender (male), n (%) | 0 (zero) | 8 (16.7 %) | 0.296 |
Age, year, median (IQR) | 13.00 (11.25, 14.00) | 13.00 (11.25, 14.00) | 1.000 |
SLEDA-2K rating | 18.00 (12.25, 21.00) | 10.00 (7.00, 18.00) | 0.034 |
Fever (yes), n (%) | 8 (66.7 %) | 25 (52.1%) | 0.364 |
Abdominal pain, n (%) | 12 (100 %) | 1 (2.1 %) | < 0.001 |
Vomiting, n (%) | 12 (100 %) | 0 (0 %) | < 0.001 |
Abdominal bloating, n (%) | 4 (33.3 %) | 0 (0 %) | < 0.001 |
Diarrhoea, n (%) | 0 (0 %) | 1 (2.1 %) | 1.000 |
Mouth ulcers, n (%) | 2 (16.7 %) | 10 (20.8%) | 1.000 |
Rash (yes), n (%) | 4 (33.3 %) | 24 (50.0 %) | 0.301 |
RP (yes), n (%) | 2 (16.7 %) | 0 (0 %) | 0.037 |
Pleural effusion (yes), n (%) | 5 (41.7 %) | 5 (10.4 %) | 0.030 |
Splenic infarction (yes), n (%) | 2 (16.7 %) | 0 (0 %) | 0.037 |
Renal involvement (yes), n (%) | 10 (83.3 %) | 25 (52.1 %) | 0.050 |
Arthritis, n (%) | 1 (8.3 %) | 8 (16.7 %) | 0.786 |
Neurologic involvement, n (%) | 5 (41.7 %) | 7 (14.6 %) | 0.09 |
Acute pericarditis, n (%) | 1 (8.33 %) | 1 (2.08 %) | 0.281 |
MAS | 3 (25 %) | 0 (0 %) | < 0.001 |